Recombinant Factor VIII (BAY81-8973)
12954
Phase 3 mab completed
Quick answer
Recombinant Factor VIII (BAY81-8973) for Blood Coagulation Disorders is a Phase 3 program (mab) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Blood Coagulation Disorders
- Phase
- Phase 3
- Modality
- mab
- Status
- completed